Old Web
English
Sign In
Acemap
>
authorDetail
>
Véronique de Mas
Véronique de Mas
Medicine
Immunology
Oncology
Azacitidine
Myeloid leukemia
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine
2018
Blood
Pierre Bories
Naïs Prade
Stéphanie Lagarde
Bastien Cabarrou
Julien Plenecassagnes
Isabelle Luquet
Véronique de Mas
Thomas Filleron
Manon Cassou
Audrey Sarry
Luc-Matthieu Fornecker
Célestine Simand
Sarah Bertoli
Hinrich Gronemeyer
Christian Recher
Eric Delabesse
Show All
Source
Cite
Save
Citations (0)
Exome Sequencing Identifies Mecom Missense Variant As Prognostic Marker for Overall Survival of Elderly Acute Myeloid Patients Treated with Azacitidine
2018
Blood
Pierre Bories
Naïs Prade
Bastien Cabarrou
Stéphanie Lagarde
Julien Plenecassagnes
Isabelle Luquet
Véronique de Mas
Thomas Filleron
Manon Cassou
Audrey Sarry
Luc-Matthieu Fornecker
Célestine Simand
Sarah Bertoli
Hinrich Gronemeyer
Christian Recher
Eric Delabesse
Show All
Source
Cite
Save
Citations (0)
Number of Mutations and Type of Prior Myeloproliferative Neoplasm Are Prognostic Factors in Acute Myeloid Leukemia Post Myeloproliferative Neoplasms
2018
Blood
Edmond Chiche
Sarah Bonnet
Sarah Bertoli
Andrew Kuykendall
Lauris Gastaud
Pascal Boulay
Véronique de Mas
Eric Delabesse
Alice Marceau-Renaut
Claude Preudhomme
Anne Murati
David A. Sallman
S. Dominique Raynaud
Christian Recher
Norbert Vey
Thomas Cluzeau
Show All
Source
Cite
Save
Citations (1)
Role des seconds messagers lipidiques dans la reponse des cellules de leucemies aigues myeloides a la daunorubicine : implication potentielle dans la resistance des progeniteurs leucemiques
1998
Véronique de Mas
Show All
Source
Cite
Save
Citations (0)
1